ONTOLOGY REPORT - ANNOTATIONS
| Term: | organic heterocyclic compound |
|
| Accession: | CHEBI:24532
|
browse the term
|
| Definition: | A cyclic compound having as ring members atoms of carbon and at least of one other element. |
| Synonyms: | related_synonym: | organic heterocycle; organic heterocyclic compounds |
|
|
(-)-anisomycin
|
| G |
Ago2 |
argonaute RISC catalytic component 2 |
|
increases phosphorylation |
ISO |
7 |
110,827,857 |
110,865,589 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
increases phosphorylation |
ISO |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
multiple interactions |
ISO |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases phosphorylation |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases phosphorylation |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
decreases expression |
ISO |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
increases phosphorylation |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
increases phosphorylation |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases phosphorylation |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases localization |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
1 |
78,668,497 |
78,673,330 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
multiple interactions |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
decreases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
multiple interactions |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
increases activity |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases activity |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
increases activity |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
multiple interactions |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
multiple interactions |
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
increases expression |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
decreases expression |
EXP |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases phosphorylation |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
increases phosphorylation |
ISO |
9 |
9,788,378 |
9,797,639 |
RGD:6480464 |
CTD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
multiple interactions |
ISO |
9 |
9,788,378 |
9,797,639 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Zak |
sterile alpha motif and leucine zipper containing kinase AZK |
|
multiple interactions |
ISO |
3 |
54,767,724 |
54,915,022 |
RGD:6480464 |
CTD |
amoxicillin
|
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
ampicillin
|
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
decreases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Agpat9 |
1-acylglycerol-3-phosphate O-acyltransferase 9 |
|
decreases expression |
ISO |
14 |
9,998,566 |
10,050,154 |
RGD:6480464 |
CTD |
| G |
Akr1b10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
|
decreases expression |
ISO |
4 |
61,755,871 |
61,771,264 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
decreases expression |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Amot |
angiomotin |
|
increases expression |
ISO |
X |
33,018,434 |
33,062,515 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
increases expression |
ISO |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
decreases expression |
ISO |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
increases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases response to substance |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Car9 |
carbonic anhydrase 9 |
|
increases expression |
ISO |
5 |
59,986,413 |
59,993,015 |
RGD:6480464 |
CTD |
| G |
Ccpg1 |
cell cycle progression 1 |
|
decreases expression |
ISO |
8 |
77,724,315 |
77,768,060 |
RGD:6480464 |
CTD |
| G |
Chst15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
increases expression |
ISO |
1 |
191,708,603 |
191,737,958 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Clgn |
calmegin |
|
decreases expression |
ISO |
19 |
26,404,126 |
26,436,081 |
RGD:6480464 |
CTD |
| G |
Clic3 |
chloride intracellular channel 3 |
|
increases expression |
ISO |
3 |
3,622,894 |
3,624,805 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
increases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
|
decreases expression |
ISO |
7 |
10,106,525 |
10,114,960 |
RGD:6480464 |
CTD |
| G |
Csta |
cystatin A (stefin A) |
|
decreases expression |
ISO |
11 |
66,456,248 |
66,467,253 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
increases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
increases expression |
ISO |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Esm1 |
endothelial cell-specific molecule 1 |
|
decreases expression |
ISO |
2 |
44,626,010 |
44,634,748 |
RGD:6480464 |
CTD |
| G |
Filip1l |
filamin A interacting protein 1-like |
|
increases expression |
ISO |
11 |
43,788,676 |
43,859,932 |
RGD:6480464 |
CTD |
| G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
|
increases expression |
ISO |
1 |
86,095,551 |
86,098,079 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
decreases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
decreases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Hoxd1 |
homeo box D1 |
|
increases expression |
ISO |
3 |
57,377,839 |
57,379,978 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Jdp2 |
Jun dimerization protein 2 |
|
decreases expression |
ISO |
6 |
109,708,745 |
109,740,375 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lppr1 |
lipid phosphate phosphatase-related protein type 1 |
|
increases expression |
ISO |
5 |
65,982,029 |
66,115,218 |
RGD:6480464 |
CTD |
| G |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
|
increases expression |
ISO |
1 |
186,201,083 |
186,204,364 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mtss1l |
metastasis suppressor 1-like |
|
increases expression |
ISO |
19 |
40,640,947 |
40,661,240 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
increases expression |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Pabpc1l |
poly(A) binding protein, cytoplasmic 1-like |
|
decreases expression |
ISO |
3 |
154,959,889 |
154,992,338 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
increases expression |
ISO |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
increases expression |
ISO |
17 |
78,241,182 |
78,268,272 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
increases expression |
ISO |
9 |
8,723,620 |
8,731,837 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
increases expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
decreases expression |
ISO |
5 |
77,010,809 |
77,029,326 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
increases expression |
ISO |
4 |
161,041,242 |
161,045,145 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
increases expression |
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:6480464 |
CTD |
| G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
|
decreases expression |
ISO |
3 |
153,849,825 |
153,890,111 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc22a15 |
solute carrier family 22, member 15 |
|
decreases expression |
ISO |
2 |
196,953,291 |
197,013,763 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
increases expression |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (amino acid transporter), member 14 |
|
increases expression |
ISO |
X |
12,048,993 |
12,072,434 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression |
ISO |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
decreases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Smim14 |
small integral membrane protein 14 |
|
decreases expression |
ISO |
14 |
45,477,213 |
45,520,785 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
decreases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
increases expression |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
decreases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
increases expression |
ISO |
16 |
18,108,914 |
18,122,956 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
increases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
| G |
Ttyh3 |
tweety homolog 3 (Drosophila) |
|
increases expression |
ISO |
12 |
14,463,541 |
14,491,939 |
RGD:6480464 |
CTD |
| G |
Tube1 |
tubulin, epsilon 1 |
|
decreases expression |
ISO |
20 |
43,280,097 |
43,298,415 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
decreases expression |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
benzylpenicillin
|
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
increases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
cefaclor
|
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
cefaloridine
|
| G |
Aadac |
arylacetamide deacetylase |
|
increases expression |
EXP |
2 |
149,348,935 |
149,360,181 |
RGD:6480464 |
CTD |
| G |
Aass |
aminoadipate-semialdehyde synthase |
|
decreases expression |
EXP |
4 |
49,479,938 |
49,539,782 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
decreases expression |
EXP |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acot5 |
acyl-CoA thioesterase 5 |
|
decreases expression |
EXP |
6 |
108,114,686 |
108,122,769 |
RGD:6480464 |
CTD |
| G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
|
decreases expression |
EXP |
1 |
177,785,186 |
177,808,572 |
RGD:6480464 |
CTD |
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
decreases expression |
EXP |
1 |
199,780,772 |
199,791,855 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases expression |
EXP |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
increases expression |
EXP |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Aftph |
aftiphilin |
|
decreases expression |
EXP |
14 |
101,482,829 |
101,536,786 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
increases expression |
EXP |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
increases expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
increases expression |
EXP |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
increases expression |
EXP |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
|
increases expression |
EXP |
1 |
206,438,325 |
206,455,477 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
affects expression |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Amer2 |
APC membrane recruitment protein 2 |
|
decreases expression |
EXP |
15 |
39,469,071 |
39,471,815 |
RGD:6480464 |
CTD |
| G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
|
increases expression |
EXP |
7 |
135,966,794 |
135,969,747 |
RGD:6480464 |
CTD |
| G |
Ampd1 |
adenosine monophosphate deaminase 1 |
|
increases expression |
EXP |
2 |
198,308,512 |
198,331,019 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
increases expression |
EXP |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
EXP |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
decreases expression |
EXP |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Anlnl1 |
anillin, actin binding protein-like 1 |
|
decreases expression |
EXP |
17 |
68,547,371 |
68,559,629 |
RGD:6480464 |
CTD |
| G |
Anxa13 |
annexin A13 |
|
decreases expression |
EXP |
7 |
95,071,045 |
95,123,201 |
RGD:6480464 |
CTD |
| G |
Anxa7 |
annexin A7 |
|
increases expression |
EXP |
15 |
4,047,956 |
4,075,981 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
decreases expression |
EXP |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
increases expression |
EXP |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apoc2 |
apolipoprotein C-II |
|
increases expression |
EXP |
1 |
78,979,034 |
78,984,002 |
RGD:6480464 |
CTD |
| G |
Apold1 |
apolipoprotein L domain containing 1 |
|
decreases expression |
EXP |
4 |
171,904,804 |
171,907,686 |
RGD:6480464 |
CTD |
| G |
Arhgap35 |
Rho GTPase activating protein 35 |
|
decreases expression |
EXP |
1 |
76,757,031 |
76,824,155 |
RGD:6480464 |
CTD |
| G |
Arid5a |
AT rich interactive domain 5A (Mrf1 like) |
|
increases expression |
EXP |
9 |
35,239,813 |
35,244,452 |
RGD:6480464 |
CTD |
| G |
Asf1b |
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
|
increases expression |
EXP |
19 |
25,867,384 |
25,881,909 |
RGD:6480464 |
CTD |
| G |
Ash1l |
ash1 (absent, small, or homeotic)-like (Drosophila) |
|
decreases expression |
EXP |
2 |
181,015,194 |
181,151,274 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
EXP |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Atad1 |
ATPase family, AAA domain containing 1 |
|
increases expression |
EXP |
1 |
236,682,640 |
236,726,705 |
RGD:6480464 |
CTD |
| G |
Atad2 |
ATPase family, AAA domain containing 2 |
|
increases expression |
EXP |
7 |
94,808,296 |
94,851,986 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atl1 |
atlastin GTPase 1 |
|
increases expression |
EXP |
6 |
91,979,260 |
92,077,664 |
RGD:6480464 |
CTD |
| G |
Atp11c |
ATPase, class VI, type 11C |
|
decreases expression |
EXP |
X |
145,746,536 |
145,861,055 |
RGD:6480464 |
CTD |
| G |
Atp12a |
ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
|
increases expression |
EXP |
15 |
35,295,274 |
35,321,453 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
decreases expression |
EXP |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
decreases expression |
EXP |
13 |
57,474,131 |
57,483,142 |
RGD:6480464 |
CTD |
| G |
B3gnt7 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
|
decreases expression |
EXP |
9 |
85,069,241 |
85,073,192 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
increases expression |
EXP |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
EXP |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
increases expression |
EXP |
9 |
70,120,151 |
70,198,591 |
RGD:6480464 |
CTD |
| G |
Batf |
basic leucine zipper transcription factor, ATF-like |
|
increases expression |
EXP |
6 |
109,793,076 |
109,817,614 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bex1 |
brain expressed, X-linked 1 |
|
increases expression |
EXP |
X |
123,527,737 |
123,529,133 |
RGD:6480464 |
CTD |
| G |
Bex4 |
brain expressed, X-linked 4 |
|
increases expression |
EXP |
X |
123,442,511 |
123,443,772 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
increases expression |
EXP |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
increases expression |
EXP |
1 |
82,528,943 |
82,546,606 |
RGD:6480464 |
CTD |
| G |
Bpi |
bactericidal/permeability-increasing protein |
|
increases expression |
EXP |
3 |
148,970,965 |
148,998,795 |
RGD:6480464 |
CTD |
| G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
|
increases expression |
EXP |
10 |
74,313,004 |
74,436,532 |
RGD:6480464 |
CTD |
| G |
Bsnd |
Bartter syndrome, infantile, with sensorineural deafness (Barttin) |
|
increases expression |
EXP |
5 |
127,542,219 |
127,551,017 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
decreases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
decreases expression |
EXP |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
|
increases expression |
EXP |
10 |
108,431,984 |
108,452,099 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
decreases expression |
EXP |
3 |
14,011,115 |
14,102,744 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
increases expression |
EXP |
2 |
53,691,290 |
53,764,539 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
increases expression |
EXP |
10 |
14,621,372 |
14,679,051 |
RGD:6480464 |
CTD |
| G |
Cacng3 |
calcium channel, voltage-dependent, gamma subunit 3 |
|
increases expression |
EXP |
1 |
181,498,716 |
181,594,090 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
increases expression |
EXP |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Calb2 |
calbindin 2 |
|
decreases expression |
EXP |
19 |
40,023,072 |
40,051,150 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camkv |
CaM kinase-like vesicle-associated |
|
increases expression |
EXP |
8 |
113,205,817 |
113,220,164 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
increases expression |
EXP |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccdc113 |
coiled-coil domain containing 113 |
|
increases expression |
EXP |
19 |
9,955,006 |
9,974,998 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
EXP |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
increases expression |
EXP |
5 |
59,221,738 |
59,223,682 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl28 |
chemokine (C-C motif) ligand 28 |
|
increases expression |
EXP |
2 |
51,688,294 |
51,712,931 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
decreases expression |
EXP |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
decreases expression |
EXP |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
EXP |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
EXP |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Cd72 |
Cd72 molecule |
|
increases expression |
EXP |
5 |
59,918,085 |
59,925,437 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
EXP |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
decreases expression |
EXP |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc45 |
cell division cycle 45 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
EXP |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
decreases expression |
EXP |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkl1 |
cyclin-dependent kinase-like 1 (CDC2-related kinase) |
|
decreases expression |
EXP |
6 |
91,800,976 |
91,869,815 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
increases expression |
EXP |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Ceacam16 |
carcinoembryonic antigen-related cell adhesion molecule 16 |
|
increases expression |
EXP |
1 |
79,166,356 |
79,176,252 |
RGD:6480464 |
CTD |
| G |
Cenpk |
centromere protein K |
|
increases expression |
EXP |
2 |
35,159,157 |
35,182,167 |
RGD:6480464 |
CTD |
| G |
Cenpq |
centromere protein Q |
|
increases expression |
EXP |
9 |
15,758,645 |
15,768,747 |
RGD:6480464 |
CTD |
| G |
Ces1e |
carboxylesterase 1E |
|
decreases expression |
EXP |
19 |
14,887,900 |
14,924,363 |
RGD:6480464 |
CTD |
| G |
Ces2g |
carboxylesterase 2G |
|
decreases expression |
EXP |
19 |
34,883,453 |
34,891,042 |
RGD:6480464 |
CTD |
| G |
Cesl1 |
carboxylesterase-like 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Chaf1a |
chromatin assembly factor 1, subunit A (p150) |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Chaf1b |
chromatin assembly factor 1, subunit B (p60) |
|
increases expression |
EXP |
11 |
34,110,848 |
34,130,928 |
RGD:6480464 |
CTD |
| G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
decreases expression |
EXP |
4 |
161,217,964 |
161,251,018 |
RGD:6480464 |
CTD |
| G |
Chd6 |
chromodomain helicase DNA binding protein 6 |
|
decreases expression |
EXP |
3 |
151,741,389 |
151,924,668 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
increases expression |
EXP |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chst7 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 |
|
decreases expression |
EXP |
X |
13,817,186 |
13,853,694 |
RGD:6480464 |
CTD |
| G |
Chtf18 |
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
increases expression |
EXP |
10 |
14,988,146 |
14,996,182 |
RGD:6480464 |
CTD |
| G |
Cilp |
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
|
decreases expression |
EXP |
8 |
69,501,820 |
69,517,136 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
decreases expression |
EXP |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Cldn14 |
claudin 14 |
|
increases expression |
EXP |
11 |
34,142,138 |
34,151,928 |
RGD:6480464 |
CTD |
| G |
Clstn2 |
calsyntenin 2 |
|
decreases expression |
EXP |
8 |
102,614,117 |
103,214,037 |
RGD:6480464 |
CTD |
| G |
Cmip |
c-Maf-inducing protein |
|
decreases expression |
EXP |
19 |
47,364,495 |
47,572,096 |
RGD:6480464 |
CTD |
| G |
Cndp1 |
carnosine dipeptidase 1 (metallopeptidase M20 family) |
|
decreases expression |
EXP |
18 |
81,160,681 |
81,183,558 |
RGD:6480464 |
CTD |
| G |
Col4a4 |
collagen, type IV, alpha 4 |
|
decreases expression |
EXP |
9 |
81,866,835 |
81,910,088 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
increases expression |
EXP |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
EXP |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
increases expression |
EXP |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
decreases expression |
EXP |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Cry1 |
cryptochrome 1 (photolyase-like) |
|
increases expression |
EXP |
7 |
20,643,879 |
20,709,216 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
decreases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl13 |
chemokine (C-X-C motif) ligand 13 |
|
increases expression |
EXP |
14 |
15,126,332 |
15,131,368 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
increases expression |
EXP |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxxc4 |
CXXC finger protein 4 |
|
decreases expression |
EXP |
2 |
231,705,560 |
231,722,975 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
increases expression |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dctpp1 |
dCTP pyrophosphatase 1 |
|
increases expression |
EXP |
1 |
186,519,955 |
186,523,348 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
decreases expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
decreases expression |
EXP |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
increases expression |
EXP |
2 |
51,881,101 |
51,881,461 |
RGD:6480464 |
CTD |
| G |
Ddx39a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
increases expression |
EXP |
19 |
26,109,094 |
26,117,042 |
RGD:6480464 |
CTD |
| G |
Ddx6 |
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
|
decreases expression |
EXP |
8 |
47,573,536 |
47,605,957 |
RGD:6480464 |
CTD |
| G |
Decr2 |
2,4-dienoyl CoA reductase 2, peroxisomal |
|
decreases expression |
EXP |
10 |
15,350,593 |
15,358,640 |
RGD:6480464 |
CTD |
| G |
Dlgap1 |
discs, large (Drosophila) homolog-associated protein 1 |
|
increases expression |
EXP |
9 |
109,455,911 |
110,018,738 |
RGD:6480464 |
CTD |
| G |
Dnah7 |
dynein, axonemal, heavy chain 7 |
|
decreases expression |
EXP |
9 |
52,217,861 |
52,520,698 |
RGD:6480464 |
CTD |
| G |
Dnase1l3 |
deoxyribonuclease 1-like 3 |
|
increases expression |
EXP |
15 |
18,909,363 |
18,935,347 |
RGD:6480464 |
CTD |
| G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
increases expression |
EXP |
9 |
9,865,096 |
9,867,833 |
RGD:6480464 |
CTD |
| G |
Donson |
downstream neighbor of SON |
|
increases expression |
EXP |
11 |
31,652,219 |
31,661,872 |
RGD:6480464 |
CTD |
| G |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
|
increases expression |
EXP |
1 |
84,444,143 |
84,452,889 |
RGD:6480464 |
CTD |
| G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
|
increases expression |
EXP |
7 |
91,602,671 |
91,618,122 |
RGD:6480464 |
CTD |
| G |
Dsg2 |
desmoglein 2 |
|
increases expression |
EXP |
18 |
12,306,321 |
12,366,719 |
RGD:6480464 |
CTD |
| G |
Dtx4 |
deltex homolog 4 (Drosophila) |
|
increases expression |
EXP |
1 |
215,396,194 |
215,416,879 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
affects expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
decreases expression |
EXP |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dusp9 |
dual specificity phosphatase 9 |
|
increases expression |
EXP |
X |
159,538,012 |
159,541,937 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
increases expression |
EXP |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
increases expression |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
decreases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
decreases expression |
EXP |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Eif4h |
eukaryotic translation initiation factor 4H |
|
increases expression |
EXP |
12 |
23,148,332 |
23,164,980 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
EXP |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
increases expression |
EXP |
2 |
49,098,743 |
49,155,221 |
RGD:6480464 |
CTD |
| G |
Eme1 |
essential meiotic endonuclease 1 homolog 1 (S. pombe) |
|
decreases expression |
EXP |
10 |
83,279,086 |
83,285,091 |
RGD:6480464 |
CTD |
| G |
Emr1 |
EGF-like module containing, mucin-like, hormone receptor-like 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
increases expression |
EXP |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Espl1 |
extra spindle pole bodies homolog 1 (S. cerevisiae) |
|
decreases expression |
EXP |
7 |
141,048,197 |
141,074,383 |
RGD:6480464 |
CTD |
| G |
Exo1 |
exonuclease 1 |
|
increases expression |
EXP |
13 |
91,619,024 |
91,644,366 |
RGD:6480464 |
CTD |
| G |
F13b |
coagulation factor XIII, B polypeptide |
|
decreases expression |
EXP |
13 |
52,867,851 |
52,889,426 |
RGD:6480464 |
CTD |
| G |
Fam111a |
family with sequence similarity 111, member A |
|
decreases expression |
EXP |
1 |
215,581,410 |
215,597,220 |
RGD:6480464 |
CTD |
| G |
Fam189a2 |
family with sequence similarity 189, member A2 |
|
increases expression |
EXP |
1 |
227,335,482 |
227,410,712 |
RGD:6480464 |
CTD |
| G |
Fam71a |
family with sequence similarity 71, member A |
|
increases expression |
EXP |
13 |
107,182,184 |
107,184,364 |
RGD:6480464 |
CTD |
| G |
Fam84a |
family with sequence similarity 84, member A |
|
increases expression |
EXP |
6 |
37,782,015 |
37,786,488 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases expression |
EXP |
4 |
149,424,558 |
149,500,006 |
RGD:6480464 |
CTD |
| G |
Fbln1 |
fibulin 1 |
|
increases expression |
EXP |
7 |
123,208,154 |
123,287,289 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose-1,6-bisphosphatase 2 |
|
increases expression |
EXP |
17 |
7,824,298 |
7,841,661 |
RGD:6480464 |
CTD |
| G |
Fbxo5 |
F-box protein 5 |
|
increases expression |
EXP |
1 |
36,492,134 |
36,498,503 |
RGD:6480464 |
CTD |
| G |
Fcgr2a |
Fc fragment of IgG, low affinity IIa, receptor |
|
increases expression |
EXP |
13 |
86,898,651 |
86,911,743 |
RGD:6480464 |
CTD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
increases expression |
EXP |
13 |
86,809,011 |
86,823,599 |
RGD:6480464 |
CTD |
| G |
Fcgr3a |
Fc fragment of IgG, low affinity IIIa, receptor |
|
increases expression |
EXP |
13 |
86,867,641 |
86,877,665 |
RGD:6480464 |
CTD |
| G |
Fcnb |
ficolin B |
|
increases expression |
EXP |
3 |
7,010,989 |
7,019,366 |
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
increases expression |
EXP |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
increases expression |
EXP |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgf17 |
fibroblast growth factor 17 |
|
increases expression |
EXP |
15 |
51,038,529 |
51,044,118 |
RGD:6480464 |
CTD |
| G |
Fgl2 |
fibrinogen-like 2 |
|
increases expression |
EXP |
4 |
9,176,333 |
9,181,976 |
RGD:6480464 |
CTD |
| G |
Fhdc1 |
FH2 domain containing 1 |
|
increases expression |
EXP |
2 |
176,220,901 |
176,258,572 |
RGD:6480464 |
CTD |
| G |
Filip1 |
filamin A interacting protein 1 |
|
decreases expression |
EXP |
8 |
84,873,131 |
84,902,873 |
RGD:6480464 |
CTD |
| G |
Folh1 |
folate hydrolase 1 |
|
decreases expression |
EXP |
1 |
142,936,379 |
143,010,358 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxe1 |
forkhead box E1 (thyroid transcription factor 2) |
|
decreases expression |
EXP |
5 |
62,905,210 |
62,908,018 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
increases expression |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fyco1 |
FYVE and coiled-coil domain containing 1 |
|
decreases expression |
EXP |
8 |
128,543,895 |
128,612,184 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
decreases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Galnt13 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) |
|
increases expression |
EXP |
3 |
36,065,457 |
36,657,842 |
RGD:6480464 |
CTD |
| G |
Ganc |
glucosidase, alpha; neutral C |
|
decreases expression |
EXP |
3 |
106,892,422 |
106,944,283 |
RGD:6480464 |
CTD |
| G |
Gda |
guanine deaminase |
|
increases expression |
EXP |
1 |
224,579,794 |
224,655,298 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
decreases expression |
EXP |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
decreases expression |
EXP |
15 |
51,279,770 |
51,371,053 |
RGD:6480464 |
CTD |
| G |
Gins2 |
GINS complex subunit 2 (Psf2 homolog) |
|
increases expression |
EXP |
19 |
50,915,108 |
50,927,668 |
RGD:6480464 |
CTD |
| G |
Gins4 |
GINS complex subunit 4 (Sld5 homolog) |
|
increases expression |
EXP |
16 |
73,245,883 |
73,257,267 |
RGD:6480464 |
CTD |
| G |
Glycam1 |
glycosylation dependent cell adhesion molecule 1 |
|
increases expression |
EXP |
7 |
142,455,642 |
142,457,902 |
RGD:6480464 |
CTD |
| G |
Gmnn |
geminin |
|
increases expression |
EXP |
17 |
47,372,316 |
47,380,559 |
RGD:6480464 |
CTD |
| G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
|
increases expression |
EXP |
1 |
219,906,120 |
219,983,252 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
increases expression |
EXP |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpr135 |
G protein-coupled receptor 135 |
|
decreases expression |
EXP |
6 |
94,262,988 |
94,264,361 |
RGD:6480464 |
CTD |
| G |
Gpr19 |
G protein-coupled receptor 19 |
|
increases expression |
EXP |
4 |
171,791,727 |
171,809,215 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
decreases expression |
EXP |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gxylt1 |
glucoside xylosyltransferase 1 |
|
decreases expression |
EXP |
7 |
131,726,969 |
131,761,134 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
decreases expression |
EXP |
2 |
228,698,545 |
228,751,691 |
RGD:6480464 |
CTD |
| G |
Haus8 |
HAUS augmin-like complex, subunit 8 |
|
increases expression |
EXP |
16 |
18,418,561 |
18,434,014 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
increases expression |
EXP |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hebp1 |
heme binding protein 1 |
|
increases expression |
EXP |
4 |
172,082,424 |
172,095,053 |
RGD:6480464 |
CTD |
| G |
Hebp2 |
heme binding protein 2 |
|
increases expression |
EXP |
1 |
13,628,658 |
13,635,958 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
increases expression |
EXP |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hepacam2 |
HEPACAM family member 2 |
|
increases expression |
EXP |
4 |
28,266,853 |
28,301,151 |
RGD:6480464 |
CTD |
| G |
Hfe2 |
hemochromatosis type 2 (juvenile) |
|
decreases expression |
EXP |
2 |
191,329,644 |
191,333,525 |
RGD:6480464 |
CTD |
| G |
Hist1h1a |
histone cluster 1, H1a |
|
increases expression |
EXP |
17 |
48,526,427 |
48,527,170 |
RGD:6480464 |
CTD |
| G |
Hlx |
H2.0-like homeobox |
|
decreases expression |
EXP |
13 |
100,685,757 |
100,691,658 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmx3 |
H6 family homeobox 3 |
|
increases expression |
EXP |
1 |
191,111,769 |
191,113,733 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
increases expression |
EXP |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hrg |
histidine-rich glycoprotein |
|
decreases expression |
EXP |
11 |
80,248,578 |
80,264,179 |
RGD:6480464 |
CTD |
| G |
Hrsp12 |
heat-responsive protein 12 |
|
decreases expression |
EXP |
7 |
69,930,464 |
69,944,267 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
EXP |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
increases expression |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
increases expression |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
EXP |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
EXP |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
increases expression |
EXP |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Htr5b |
5-hydroxytryptamine (serotonin) receptor 5B |
|
increases expression |
EXP |
13 |
33,545,128 |
33,558,050 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifitm6 |
interferon induced transmembrane protein 6 |
|
increases expression |
EXP |
1 |
201,204,645 |
201,205,945 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
increases expression |
EXP |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il20ra |
interleukin 20 receptor, alpha |
|
decreases expression |
EXP |
1 |
14,965,655 |
15,009,954 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
decreases expression |
EXP |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Itpka |
inositol-trisphosphate 3-kinase A |
|
increases expression |
EXP |
3 |
106,257,482 |
106,266,160 |
RGD:6480464 |
CTD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
increases expression |
EXP |
13 |
96,044,260 |
96,138,456 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Kbtbd11 |
kelch repeat and BTB (POZ) domain containing 11 |
|
decreases expression |
EXP |
16 |
79,428,762 |
79,432,863 |
RGD:6480464 |
CTD |
| G |
Kcnh1 |
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
|
increases expression |
EXP |
13 |
108,129,617 |
108,407,815 |
RGD:6480464 |
CTD |
| G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
|
decreases expression |
EXP |
11 |
35,577,083 |
35,594,291 |
RGD:6480464 |
CTD |
| G |
Kctd1 |
potassium channel tetramerisation domain containing 1 |
|
increases expression |
EXP |
18 |
6,225,049 |
6,324,832 |
RGD:6480464 |
CTD |
| G |
Kif18a |
kinesin family member 18A |
|
decreases expression |
EXP |
3 |
94,825,019 |
94,885,158 |
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
decreases expression |
EXP |
5 |
137,473,698 |
137,498,974 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
decreases expression |
EXP |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klhl25 |
kelch-like family member 25 |
|
decreases expression |
EXP |
1 |
131,540,949 |
131,566,141 |
RGD:6480464 |
CTD |
| G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
|
decreases expression |
EXP |
3 |
105,322,270 |
105,341,927 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
increases expression |
EXP |
12 |
33,906,847 |
33,977,070 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
decreases expression |
EXP |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
increases expression |
EXP |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lars |
leucyl-tRNA synthetase |
|
decreases expression |
EXP |
18 |
35,399,197 |
35,455,759 |
RGD:6480464 |
CTD |
| G |
Lcor |
ligand dependent nuclear receptor corepressor |
|
decreases expression |
EXP |
1 |
246,702,984 |
246,800,587 |
RGD:6480464 |
CTD |
| G |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
|
decreases expression |
EXP |
17 |
13,995,034 |
14,001,255 |
RGD:6480464 |
CTD |
| G |
Lgals2 |
lectin, galactoside-binding, soluble, 2 |
|
increases expression |
EXP |
7 |
116,811,332 |
116,817,822 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhx3 |
LIM homeobox 3 |
|
decreases expression |
EXP |
3 |
4,381,890 |
4,389,132 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
increases expression |
EXP |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
decreases expression |
EXP |
18 |
52,470,605 |
52,508,022 |
RGD:6480464 |
CTD |
| G |
Lrrn3 |
leucine rich repeat neuronal 3 |
|
decreases expression |
EXP |
6 |
60,745,501 |
60,776,261 |
RGD:6480464 |
CTD |
| G |
Maf |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) |
|
decreases expression |
EXP |
19 |
45,859,510 |
45,861,454 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
increases expression |
EXP |
2 |
43,062,252 |
43,126,058 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
decreases expression |
EXP |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
increases expression |
EXP |
10 |
14,147,895 |
14,186,277 |
RGD:6480464 |
CTD |
| G |
Masp2 |
mannan-binding lectin serine peptidase 2 |
|
increases expression |
EXP |
5 |
165,682,509 |
165,696,426 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
increases expression |
EXP |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm3 |
minichromosome maintenance complex component 3 |
|
increases expression |
EXP |
9 |
19,536,922 |
19,554,871 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
increases expression |
EXP |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
increases expression |
EXP |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
increases expression |
EXP |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mcm8 |
minichromosome maintenance complex component 8 |
|
increases expression |
EXP |
3 |
120,614,429 |
120,644,673 |
RGD:6480464 |
CTD |
| G |
Mesp1 |
mesoderm posterior 1 homolog (mouse) |
|
decreases expression |
EXP |
1 |
135,571,777 |
135,573,295 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
decreases expression |
EXP |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
decreases expression |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
increases expression |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp16 |
matrix metallopeptidase 16 |
|
increases expression |
EXP |
5 |
32,352,311 |
32,586,469 |
RGD:6480464 |
CTD |
| G |
Mnd1 |
meiotic nuclear divisions 1 homolog (S. cerevisiae) |
|
increases expression |
EXP |
2 |
175,841,810 |
175,906,450 |
RGD:6480464 |
CTD |
| G |
Mns1 |
meiosis-specific nuclear structural 1 |
|
decreases expression |
EXP |
8 |
77,015,290 |
77,035,979 |
RGD:6480464 |
CTD |
| G |
Mpst |
mercaptopyruvate sulfurtransferase |
|
decreases expression |
EXP |
7 |
116,359,466 |
116,364,146 |
RGD:6480464 |
CTD |
| G |
Mpv17 |
MpV17 mitochondrial inner membrane protein |
|
decreases expression |
EXP |
6 |
25,200,452 |
25,214,909 |
RGD:6480464 |
CTD |
| G |
Mpv17l |
MPV17 mitochondrial membrane protein-like |
|
decreases expression |
EXP |
10 |
1,655,565 |
1,672,677 |
RGD:6480464 |
CTD |
| G |
Mrps36 |
mitochondrial ribosomal protein S36 |
|
increases expression |
EXP |
2 |
31,530,724 |
31,538,504 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
increases expression |
EXP |
1 |
34,759,445 |
34,800,865 |
RGD:6480464 |
CTD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
increases expression |
EXP |
4 |
117,517,611 |
117,529,128 |
RGD:6480464 |
CTD |
| G |
Myom3 |
myomesin 3 |
|
increases expression |
EXP |
5 |
154,544,049 |
154,589,658 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
decreases expression |
EXP |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Nek6 |
NIMA-related kinase 6 |
|
increases expression |
EXP |
3 |
18,348,698 |
18,381,895 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
|
increases expression |
EXP |
17 |
18,092,489 |
18,107,708 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
decreases expression |
EXP |
11 |
45,776,027 |
45,811,515 |
RGD:6480464 |
CTD |
| G |
Ngfr |
nerve growth factor receptor |
|
increases expression |
EXP |
10 |
84,262,804 |
84,281,006 |
RGD:6480464 |
CTD |
| G |
Nhp2 |
NHP2 ribonucleoprotein |
|
increases expression |
EXP |
10 |
37,137,277 |
37,140,651 |
RGD:6480464 |
CTD |
| G |
Ninj2 |
ninjurin 2 |
|
increases expression |
EXP |
4 |
156,474,781 |
156,578,361 |
RGD:6480464 |
CTD |
| G |
Nipsnap3b |
nipsnap homolog 3B (C. elegans) |
|
increases expression |
EXP |
5 |
70,448,727 |
70,481,754 |
RGD:6480464 |
CTD |
| G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
|
decreases expression |
EXP |
10 |
15,360,310 |
15,364,165 |
RGD:6480464 |
CTD |
| G |
Nop56 |
NOP56 ribonucleoprotein |
|
increases expression |
EXP |
3 |
117,887,822 |
117,892,614 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
increases expression |
EXP |
10 |
87,541,246 |
87,548,186 |
RGD:6480464 |
CTD |
| G |
Nrm |
nurim (nuclear envelope membrane protein) |
|
increases expression |
EXP |
20 |
3,035,770 |
3,039,251 |
RGD:6480464 |
CTD |
| G |
Ns5atp9 |
NS5A (hepatitis C virus) transactivated protein 9 |
|
increases expression |
EXP |
8 |
70,159,283 |
70,172,116 |
RGD:6480464 |
CTD |
| G |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
|
increases expression |
EXP |
X |
28,682,852 |
28,686,500 |
RGD:6480464 |
CTD |
| G |
Olr110 |
olfactory receptor 110 |
|
decreases expression |
EXP |
1 |
161,286,481 |
161,287,446 |
RGD:6480464 |
CTD |
| G |
Olr1583 |
olfactory receptor 1583 |
|
increases expression |
EXP |
13 |
89,424,463 |
89,425,404 |
RGD:6480464 |
CTD |
| G |
Olr16 |
olfactory receptor 16 |
|
decreases expression |
EXP |
1 |
142,435,591 |
142,436,541 |
RGD:6480464 |
CTD |
| G |
Olr1657 |
olfactory receptor 1657 |
|
increases expression |
EXP |
17 |
50,544,802 |
50,545,740 |
RGD:6480464 |
CTD |
| G |
Olr202 |
olfactory receptor 202 |
|
increases expression |
EXP |
1 |
163,080,521 |
163,081,489 |
RGD:6480464 |
CTD |
| G |
Olr390 |
olfactory receptor 390 |
|
decreases expression |
EXP |
2 |
192,188,894 |
192,189,856 |
RGD:6480464 |
CTD |
| G |
Olr46 |
olfactory receptor 46 |
|
decreases expression |
EXP |
1 |
160,247,696 |
160,248,640 |
RGD:6480464 |
CTD |
| G |
Oprl1 |
opiate receptor-like 1 |
|
increases expression |
EXP |
3 |
170,869,862 |
170,873,417 |
RGD:6480464 |
CTD |
| G |
Orc6 |
origin recognition complex, subunit 6 |
|
increases expression |
EXP |
19 |
23,116,888 |
23,124,657 |
RGD:6480464 |
CTD |
| G |
Osbpl8 |
oxysterol binding protein-like 8 |
|
decreases expression |
EXP |
7 |
50,308,713 |
50,313,369 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
increases expression |
EXP |
2 |
56,080,700 |
56,121,463 |
RGD:6480464 |
CTD |
| G |
Oxgr1 |
oxoglutarate (alpha-ketoglutarate) receptor 1 |
|
increases expression |
EXP |
15 |
105,089,715 |
105,090,728 |
RGD:6480464 |
CTD |
| G |
Padi6 |
peptidyl arginine deiminase, type VI |
|
increases expression |
EXP |
5 |
159,561,456 |
159,576,742 |
RGD:6480464 |
CTD |
| G |
Palb2 |
partner and localizer of BRCA2 |
|
increases expression |
EXP |
1 |
180,928,710 |
180,952,518 |
RGD:6480464 |
CTD |
| G |
Pask |
PAS domain containing serine/threonine kinase |
|
increases expression |
EXP |
9 |
92,582,177 |
92,623,004 |
RGD:6480464 |
CTD |
| G |
Pbk |
PDZ binding kinase |
|
decreases expression |
EXP |
15 |
45,227,251 |
45,238,096 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
decreases expression |
EXP |
14 |
56,609,036 |
57,323,892 |
RGD:6480464 |
CTD |
| G |
Pcdh9 |
protocadherin 9 |
|
decreases expression |
EXP |
15 |
75,827,180 |
76,739,147 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
increases expression |
EXP |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pfn3 |
profilin 3 |
|
decreases expression |
EXP |
17 |
15,261,648 |
15,262,175 |
RGD:6480464 |
CTD |
| G |
Phf15 |
PHD finger protein 15 |
|
decreases expression |
EXP |
10 |
37,338,457 |
37,379,931 |
RGD:6480464 |
CTD |
| G |
Pipox |
pipecolic acid oxidase |
|
increases expression |
EXP |
10 |
63,920,814 |
63,933,307 |
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
EXP |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
decreases expression |
EXP |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
|
increases expression |
EXP |
10 |
12,982,319 |
12,993,706 |
RGD:6480464 |
CTD |
| G |
Pla1a |
phospholipase A1 member A |
|
increases expression |
EXP |
11 |
64,099,837 |
64,137,353 |
RGD:6480464 |
CTD |
| G |
Plek2 |
pleckstrin 2 |
|
increases expression |
EXP |
6 |
101,523,558 |
101,541,773 |
RGD:6480464 |
CTD |
| G |
Plekha5 |
pleckstrin homology domain containing, family A member 5 |
|
decreases expression |
EXP |
4 |
177,616,038 |
177,784,751 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
decreases expression |
EXP |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Pola2 |
polymerase (DNA directed), alpha 2, accessory subunit |
|
increases expression |
EXP |
1 |
208,573,153 |
208,597,195 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
EXP |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pole |
polymerase (DNA directed), epsilon, catalytic subunit |
|
increases expression |
EXP |
12 |
46,491,498 |
46,539,988 |
RGD:6480464 |
CTD |
| G |
Ppa1 |
pyrophosphatase (inorganic) 1 |
|
increases expression |
EXP |
20 |
29,015,647 |
29,042,399 |
RGD:6480464 |
CTD |
| G |
Ppm1j |
protein phosphatase, Mg2+/Mn2+ dependent, 1J |
|
increases expression |
EXP |
2 |
200,039,684 |
200,044,698 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
decreases expression |
EXP |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
decreases expression |
EXP |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I, beta |
|
increases expression |
EXP |
12 |
16,025,867 |
16,131,129 |
RGD:6480464 |
CTD |
| G |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
|
decreases expression |
EXP |
1 |
85,546,014 |
85,559,530 |
RGD:6480464 |
CTD |
| G |
Prrx1 |
paired related homeobox 1 |
|
decreases expression |
EXP |
13 |
78,961,648 |
79,028,882 |
RGD:6480464 |
CTD |
| G |
Prss35 |
protease, serine, 35 |
|
decreases expression |
EXP |
8 |
92,009,530 |
92,025,563 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
increases expression |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Ptbp1 |
polypyrimidine tract binding protein 1 |
|
increases expression |
EXP |
7 |
11,355,538 |
11,365,188 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
increases expression |
EXP |
5 |
77,010,809 |
77,029,326 |
RGD:6480464 |
CTD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
decreases expression |
EXP |
12 |
36,501,886 |
36,558,055 |
RGD:6480464 |
CTD |
| G |
Ptprb |
protein tyrosine phosphatase, receptor type, B |
|
decreases expression |
EXP |
7 |
55,613,557 |
55,714,216 |
RGD:6480464 |
CTD |
| G |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
|
increases expression |
EXP |
6 |
143,787,884 |
144,549,042 |
RGD:6480464 |
CTD |
| G |
Ptrh1 |
peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae) |
|
increases expression |
EXP |
3 |
11,733,944 |
11,764,375 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
increases expression |
EXP |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Rab11fip3 |
RAB11 family interacting protein 3 (class II) |
|
decreases expression |
EXP |
10 |
15,248,355 |
15,332,036 |
RGD:6480464 |
CTD |
| G |
Rab31 |
RAB31, member RAS oncogene family |
|
decreases expression |
EXP |
9 |
104,408,546 |
104,543,084 |
RGD:6480464 |
CTD |
| G |
Rad18 |
RAD18 homolog (S. cerevisiae) |
|
increases expression |
EXP |
4 |
148,452,664 |
148,543,743 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
affects activity |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbp2 |
retinol binding protein 2, cellular |
|
increases expression |
EXP |
8 |
103,665,461 |
103,685,771 |
RGD:6480464 |
CTD |
| G |
Recql4 |
RecQ protein-like 4 |
|
increases expression |
EXP |
7 |
114,752,863 |
114,760,027 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects activity |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rfc3 |
replication factor C (activator 1) 3 |
|
increases expression |
EXP |
12 |
3,224,493 |
3,235,256 |
RGD:6480464 |
CTD |
| G |
Rfc4 |
replication factor C (activator 1) 4 |
|
increases expression |
EXP |
11 |
79,935,273 |
79,950,589 |
RGD:6480464 |
CTD |
| G |
RGD1306820 |
similar to erythroid differentiation-related factor 1 |
|
decreases expression |
EXP |
1 |
193,134,878 |
193,171,942 |
RGD:6480464 |
CTD |
| G |
RGD1309903 |
similar to mKIAA1244 protein |
|
decreases expression |
EXP |
1 |
13,680,369 |
13,841,423 |
RGD:6480464 |
CTD |
| G |
RGD1559582 |
similar to Nol5a_predicted protein |
|
increases expression |
EXP |
13 |
28,755,733 |
28,755,936 |
RGD:6480464 |
CTD |
| G |
RGD1559671 |
similar to M2 ribonucleotide reductase |
|
decreases expression |
EXP |
6 |
42,357,656 |
42,358,000 |
RGD:6480464 |
CTD |
| G |
RGD1561843 |
similar to 60S ribosomal protein L23a |
|
increases expression |
EXP |
1 |
2,231,299 |
2,231,646 |
RGD:6480464 |
CTD |
| G |
RGD1561897 |
similar to Serine/threonine-protein kinase Kist (Kinase interacting with stathmin) |
|
increases expression |
EXP |
17 |
49,379,258 |
49,380,521 |
RGD:6480464 |
CTD |
| G |
RGD1561944 |
similar to 60S ribosomal protein L32 |
|
decreases expression |
EXP |
8 |
88,843,584 |
88,844,077 |
RGD:6480464 |
CTD |
| G |
RGD1562392 |
similar to Sulfotransferase K1 (rSULT1C2) |
|
decreases expression |
EXP |
9 |
623,164 |
634,729 |
RGD:6480464 |
CTD |
| G |
RGD1563319 |
similar to RIKEN cDNA 6330512M04 gene |
|
increases expression |
EXP |
1 |
202,599,703 |
202,617,230 |
RGD:6480464 |
CTD |
| G |
RGD1563441 |
similar to RIKEN cDNA A030009H04 |
|
increases expression |
EXP |
10 |
56,133,424 |
56,134,096 |
RGD:6480464 |
CTD |
| G |
RGD1563689 |
similar to KIAA0853 protein |
|
decreases expression |
EXP |
15 |
42,036,497 |
42,043,111 |
RGD:6480464 |
CTD |
| G |
RGD1563825 |
similar to ENSANGP00000020885 |
|
decreases expression |
EXP |
16 |
21,506,850 |
21,514,524 |
RGD:6480464 |
CTD |
| G |
RGD1564040 |
similar to methylenetetrahydrofolate dehydrogenase (NAD) (EC 1.5.1.15)/methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9) precursor |
|
increases expression |
EXP |
5 |
122,694,391 |
122,695,440 |
RGD:6480464 |
CTD |
| G |
RGD1564324 |
similar to dehydrogenase/reductase member 2 |
|
increases expression |
EXP |
15 |
33,270,015 |
33,272,662 |
RGD:6480464 |
CTD |
| G |
RGD1564606 |
similar to 60S ribosomal protein L23a |
|
increases expression |
EXP |
2 |
38,164,306 |
38,165,356 |
RGD:6480464 |
CTD |
| G |
RGD1564866 |
similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) |
|
increases expression |
EXP |
X |
34,325,790 |
34,328,359 |
RGD:6480464 |
CTD |
| G |
RGD1564999 |
similar to isopentenyl-diphosphate delta isomerase 2 |
|
decreases expression |
EXP |
17 |
72,412,210 |
72,417,701 |
RGD:6480464 |
CTD |
| G |
RGD1565017 |
similar to RS21-C6 protein |
|
increases expression |
EXP |
16 |
1,429,516 |
1,430,026 |
RGD:6480464 |
CTD |
| G |
RGD1565166 |
similar to MGC45438 protein |
|
increases expression |
EXP |
10 |
10,476,014 |
10,485,110 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rgs11 |
regulator of G-protein signaling 11 |
|
increases expression |
EXP |
10 |
15,469,922 |
15,478,157 |
RGD:6480464 |
CTD |
| G |
Rhcg |
Rh family, C glycoprotein |
|
increases expression |
EXP |
1 |
135,361,418 |
135,386,461 |
RGD:6480464 |
CTD |
| G |
Rhobtb1 |
Rho-related BTB domain containing 1 |
|
decreases expression |
EXP |
20 |
20,089,811 |
20,166,069 |
RGD:6480464 |
CTD |
| G |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
|
increases expression |
EXP |
1 |
87,853,620 |
87,917,634 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
increases expression |
EXP |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rpl23a |
ribosomal protein L23a |
|
increases expression |
EXP |
10 |
64,451,931 |
64,454,617 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
decreases expression |
EXP |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Runx1t1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
decreases expression |
EXP |
5 |
28,230,322 |
28,338,441 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
increases expression |
EXP |
13 |
83,256,823 |
83,298,724 |
RGD:6480464 |
CTD |
| G |
Scgb3a1 |
secretoglobin, family 3A, member 1 |
|
increases expression |
EXP |
10 |
35,125,569 |
35,126,876 |
RGD:6480464 |
CTD |
| G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
|
increases expression |
EXP |
18 |
37,200,474 |
37,203,396 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
increases expression |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sectm1 |
secreted and transmembrane 1 |
|
increases expression |
EXP |
10 |
110,283,747 |
110,294,733 |
RGD:6480464 |
CTD |
| G |
Sema4c |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C |
|
decreases expression |
EXP |
9 |
35,492,647 |
35,503,102 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
EXP |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
increases expression |
EXP |
12 |
21,544,434 |
21,572,232 |
RGD:6480464 |
CTD |
| G |
Sh3bp2 |
SH3-domain binding protein 2 |
|
increases expression |
EXP |
14 |
81,818,728 |
81,855,875 |
RGD:6480464 |
CTD |
| G |
Shroom4 |
shroom family member 4 |
|
decreases expression |
EXP |
X |
29,125,307 |
29,334,579 |
RGD:6480464 |
CTD |
| G |
Siglec5 |
sialic acid binding Ig-like lectin 5 |
|
increases expression |
EXP |
1 |
93,734,855 |
93,743,230 |
RGD:6480464 |
CTD |
| G |
Ska1 |
spindle and kinetochore associated complex subunit 1 |
|
decreases expression |
EXP |
18 |
70,988,118 |
70,998,430 |
RGD:6480464 |
CTD |
| G |
Slc15a3 |
solute carrier family 15, member 3 |
|
increases expression |
EXP |
1 |
213,341,322 |
213,356,103 |
RGD:6480464 |
CTD |
| G |
Slc16a12 |
solute carrier family 16, member 12 (monocarboxylic acid transporter 12) |
|
decreases expression |
EXP |
1 |
238,643,040 |
238,665,699 |
RGD:6480464 |
CTD |
| G |
Slc16a14 |
solute carrier family 16, member 14 (monocarboxylic acid transporter 14) |
|
decreases expression |
EXP |
9 |
84,170,601 |
84,195,055 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
increases expression |
EXP |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc22a23 |
solute carrier family 22, member 23 |
|
decreases expression |
EXP |
17 |
36,883,334 |
37,049,975 |
RGD:6480464 |
CTD |
| G |
Slc22a5 |
solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
decreases expression |
EXP |
10 |
39,311,729 |
39,338,718 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases import |
EXP |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc35d2 |
solute carrier family 35, member D2 |
|
increases expression |
EXP |
17 |
6,515,164 |
6,546,280 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
increases expression |
EXP |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc41a2 |
solute carrier family 41, member 2 |
|
increases expression |
EXP |
7 |
22,583,232 |
22,669,674 |
RGD:6480464 |
CTD |
| G |
Slc46a3 |
solute carrier family 46, member 3 |
|
increases expression |
EXP |
12 |
7,698,889 |
7,715,296 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
decreases expression |
EXP |
14 |
20,381,545 |
20,739,216 |
RGD:6480464 |
CTD |
| G |
Slc5a3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
|
increases expression |
EXP |
11 |
32,063,275 |
32,065,721 |
RGD:6480464 |
CTD |
| G |
Slc7a10 |
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 |
|
increases expression |
EXP |
1 |
87,695,658 |
87,711,595 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression |
EXP |
19 |
52,120,728 |
52,149,332 |
RGD:6480464 |
CTD |
| G |
Slc7a7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
decreases expression |
EXP |
15 |
32,431,748 |
32,471,526 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
decreases expression |
EXP |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Smyd1 |
SET and MYND domain containing 1 |
|
increases expression |
EXP |
4 |
104,423,556 |
104,475,134 |
RGD:6480464 |
CTD |
| G |
Snapc2 |
small nuclear RNA activating complex, polypeptide 2 |
|
increases expression |
EXP |
12 |
1,534,904 |
1,538,056 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
decreases expression |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Spetex-2B |
Spetex-2B protein |
|
increases expression |
EXP |
15 |
6,011,208 |
6,014,735 |
RGD:6480464 |
CTD |
| G |
Spetex-2D |
Spetex-2D protein |
|
increases expression |
EXP |
15 |
5,922,760 |
5,925,028 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
increases expression |
EXP |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
decreases expression |
EXP |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Srpr |
signal recognition particle receptor ('docking protein') |
|
decreases expression |
EXP |
8 |
34,992,187 |
34,998,270 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stk35 |
serine/threonine kinase 35 |
|
increases expression |
EXP |
3 |
117,407,255 |
117,435,699 |
RGD:6480464 |
CTD |
| G |
Stra6 |
stimulated by retinoic acid 6 |
|
decreases expression |
EXP |
8 |
61,920,772 |
61,939,791 |
RGD:6480464 |
CTD |
| G |
Sult1c2 |
sulfotransferase family, cytosolic, 1C, member 2 |
|
decreases expression |
EXP |
9 |
972,522 |
998,125 |
RGD:6480464 |
CTD |
| G |
Sult1c2a |
sulfotransferase family, cytosolic, 1C, member 2a |
|
decreases expression |
EXP |
9 |
1,030,264 |
1,168,243 |
RGD:6480464 |
CTD |
| G |
Sult4a1 |
sulfotransferase family 4A, member 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Surf6 |
surfeit 6 |
|
decreases expression |
EXP |
3 |
5,790,323 |
5,801,072 |
RGD:6480464 |
CTD |
| G |
Susd2 |
sushi domain containing 2 |
|
decreases expression |
EXP |
20 |
13,435,257 |
13,442,683 |
RGD:6480464 |
CTD |
| G |
Syne1 |
spectrin repeat containing, nuclear envelope 1 |
|
decreases expression |
EXP |
1 |
35,803,552 |
36,269,628 |
RGD:6480464 |
CTD |
| G |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
|
decreases expression |
EXP |
6 |
98,457,147 |
98,601,686 |
RGD:6480464 |
CTD |
| G |
Sytl5 |
synaptotagmin-like 5 |
|
increases expression |
EXP |
X |
24,945,436 |
25,034,025 |
RGD:6480464 |
CTD |
| G |
Tac3 |
tachykinin 3 |
|
increases expression |
EXP |
7 |
67,717,068 |
67,723,674 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
decreases expression |
EXP |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tcf12 |
transcription factor 12 |
|
decreases expression |
EXP |
8 |
76,311,327 |
76,498,091 |
RGD:6480464 |
CTD |
| G |
Tcf19 |
transcription factor 19 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Ticrr |
TOPBP1-interacting checkpoint and replication regulator |
|
increases expression |
EXP |
1 |
135,428,695 |
135,471,349 |
RGD:6480464 |
CTD |
| G |
Timeless |
timeless circadian clock |
|
increases expression |
EXP |
7 |
1,516,568 |
1,540,512 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
increases expression |
EXP |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tmem163 |
transmembrane protein 163 |
|
increases expression |
EXP |
13 |
40,144,073 |
40,327,947 |
RGD:6480464 |
CTD |
| G |
Tmem252 |
transmembrane protein 252 |
|
decreases expression |
EXP |
1 |
228,097,429 |
228,102,637 |
RGD:6480464 |
CTD |
| G |
Tmem63c |
transmembrane protein 63c |
|
increases expression |
EXP |
6 |
111,159,623 |
111,223,801 |
RGD:6480464 |
CTD |
| G |
Tmem86a |
transmembrane protein 86A |
|
decreases expression |
EXP |
1 |
97,604,511 |
97,608,861 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
increases expression |
EXP |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
EXP |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tns4 |
tensin 4 |
|
increases expression |
EXP |
10 |
87,849,160 |
87,868,697 |
RGD:6480464 |
CTD |
| G |
Tonsl |
tonsoku-like, DNA repair protein |
|
increases expression |
EXP |
7 |
114,674,549 |
114,689,284 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
increases expression |
EXP |
1 |
97,186,071 |
97,207,551 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Tril |
TLR4 interactor with leucine-rich repeats |
|
decreases expression |
EXP |
4 |
82,177,050 |
82,181,895 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases expression |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Tsx |
testis specific X-linked gene |
|
increases expression |
EXP |
X |
91,398,417 |
91,408,922 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
increases expression |
EXP |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Ttk |
Ttk protein kinase |
|
decreases expression |
EXP |
8 |
88,906,665 |
88,944,613 |
RGD:6480464 |
CTD |
| G |
Ttll2 |
tubulin tyrosine ligase-like family, member 2 |
|
increases expression |
EXP |
1 |
47,623,758 |
47,625,536 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
increases expression |
EXP |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Tubb6 |
tubulin, beta 6 class V |
|
increases expression |
EXP |
18 |
63,919,776 |
63,929,415 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
increases expression |
EXP |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
EXP |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
|
increases expression |
EXP |
3 |
68,000,239 |
68,016,331 |
RGD:6480464 |
CTD |
| G |
Ubl7 |
ubiquitin-like 7 (bone marrow stromal cell-derived) |
|
increases expression |
EXP |
8 |
61,690,384 |
61,707,678 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression |
EXP |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases expression |
EXP |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
increases expression |
EXP |
14 |
22,499,152 |
22,522,842 |
RGD:6480464 |
CTD |
| G |
Uhmk1 |
U2AF homology motif (UHM) kinase 1 |
|
increases expression |
EXP |
13 |
86,010,861 |
86,025,965 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
increases expression |
EXP |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
| G |
Usp24 |
ubiquitin specific peptidase 24 |
|
decreases expression |
EXP |
5 |
127,371,225 |
127,500,521 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vpreb3 |
pre-B lymphocyte 3 |
|
increases expression |
EXP |
20 |
13,116,299 |
13,117,609 |
RGD:6480464 |
CTD |
| G |
Wbscr28 |
Williams-Beuren syndrome chromosome region 28 |
|
increases expression |
EXP |
12 |
22,858,647 |
22,863,206 |
RGD:6480464 |
CTD |
| G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
|
increases expression |
EXP |
15 |
23,194,973 |
23,228,773 |
RGD:6480464 |
CTD |
| G |
Zc3h13 |
zinc finger CCCH type containing 13 |
|
decreases expression |
EXP |
15 |
56,155,138 |
56,219,559 |
RGD:6480464 |
CTD |
| G |
Zdhhc18 |
zinc finger, DHHC-type containing 18 |
|
decreases expression |
EXP |
5 |
151,447,177 |
151,474,022 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
decreases expression |
EXP |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfp367 |
zinc finger protein 367 |
|
increases expression |
EXP |
17 |
6,492,142 |
6,511,271 |
RGD:6480464 |
CTD |
| G |
Zfp36l3 |
zinc finger protein 36, C3H type-like 3 |
|
increases expression |
EXP |
X |
140,991,888 |
140,994,056 |
RGD:6480464 |
CTD |
| G |
Zfyve20 |
zinc finger, FYVE domain containing 20 |
|
decreases expression |
EXP |
4 |
126,366,759 |
126,395,365 |
RGD:6480464 |
CTD |
cefalotin
|
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
cefazolin
|
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
cefdinir
|
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
cefepime
|
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
cefixime
|
| G |
Rab8a |
RAB8A, member RAS oncogene family |
|
multiple interactions |
ISO |
16 |
18,078,519 |
18,099,882 |
RGD:6480464 |
CTD |
| G |
Rab8a |
RAB8A, member RAS oncogene family |
|
increases uptake |
ISO |
16 |
18,078,519 |
18,099,882 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
increases uptake |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
cefmetazole
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
cefoperazone
|
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
multiple interactions |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
cefotaxime
|
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
cefotiam
|
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
ceftazidime pentahydrate
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
ceftibuten
|
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
ceftizoxime
|
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
ceftriaxone
|
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
EXP |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
cefuroxime
|
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
cephalosporin C
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
cephradine
|
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
cloxacillin
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
cycloheximide
|
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
multiple interactions |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
multiple interactions |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
decreases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
multiple interactions |
EXP |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
multiple interactions |
EXP |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
multiple interactions |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
multiple interactions |
ISO |
16 |
71,446,498 |
71,526,108 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2B receptor |
|
multiple interactions |
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases localization |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
multiple interactions |
ISO |
6 |
98,923,105 |
98,928,505 |
RGD:6480464 |
CTD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
multiple interactions |
ISO |
6 |
73,010,779 |
73,354,520 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
multiple interactions |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
multiple interactions |
ISO |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
multiple interactions |
ISO |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alpi |
alkaline phosphatase, intestinal |
|
multiple interactions |
EXP |
9 |
85,892,887 |
85,896,353 |
RGD:6480464 |
CTD |
| G |
Amhr2 |
anti-Mullerian hormone receptor, type II |
|
multiple interactions |
ISO |
7 |
141,203,832 |
141,212,653 |
RGD:6480464 |
CTD |
| G |
Ankrd27 |
ankyrin repeat domain 27 (VPS9 domain) |
|
multiple interactions |
ISO |
1 |
88,117,683 |
88,139,762 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
decreases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
multiple interactions |
EXP |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
multiple interactions |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Armc5 |
armadillo repeat containing 5 |
|
multiple interactions |
ISO |
1 |
187,496,189 |
187,502,956 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
|
multiple interactions |
ISO |
9 |
90,758,693 |
90,774,541 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 |
|
multiple interactions |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
multiple interactions |
ISO |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
|
multiple interactions |
ISO |
3 |
95,747,735 |
95,786,852 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases degradation |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
multiple interactions |
ISO |
8 |
113,470,871 |
113,483,433 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
multiple interactions |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Deaf1 |
DEAF1 transcription factor |
|
multiple interactions |
ISO |
1 |
201,491,091 |
201,524,767 |
RGD:6480464 |
CTD |
| G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
|
multiple interactions |
ISO |
13 |
98,242,981 |
98,249,638 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
multiple interactions |
ISO |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
decreases activity |
ISO |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine, type III |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dleu2 |
deleted in lymphocytic leukemia 2 |
|
multiple interactions |
ISO |
15 |
40,793,673 |
40,836,681 |
RGD:6480464 |
CTD |
| G |
Dleu2 |
deleted in lymphocytic leukemia 2 |
|
increases expression |
ISO |
15 |
40,793,673 |
40,836,681 |
RGD:6480464 |
CTD |
| G |
Dnajb5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
|
multiple interactions |
ISO |
5 |
59,437,972 |
59,446,618 |
RGD:6480464 |
CTD |
| G |
Dnase1l3 |
deoxyribonuclease 1-like 3 |
|
increases expression |
ISO |
15 |
18,909,363 |
18,935,347 |
RGD:6480464 |
CTD |
| G |
Dnm1l |
dynamin 1-like |
|
increases expression |
ISO |
11 |
86,617,236 |
86,665,861 |
RGD:6480464 |
CTD |
| G |
Dnm1l |
dynamin 1-like |
|
multiple interactions |
ISO |
11 |
86,617,236 |
86,665,861 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
increases expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
multiple interactions |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
increases expression |
ISO |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
multiple interactions |
ISO |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
|
multiple interactions |
ISO |
5 |
156,809,618 |
156,979,249 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled family receptor 7 |
|
multiple interactions |
ISO |
9 |
58,063,740 |
58,066,559 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ift27 |
intraflagellar transport 27 homolog (Chlamydomonas) |
|
multiple interactions |
ISO |
7 |
116,080,404 |
116,096,150 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
increases expression |
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
multiple interactions |
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
multiple interactions |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
multiple interactions |
ISO |
1 |
136,552,358 |
136,642,545 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
multiple interactions |
ISO |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itpk1 |
inositol-tetrakisphosphate 1-kinase |
|
multiple interactions |
ISO |
6 |
126,837,135 |
126,969,350 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
multiple interactions |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
multiple interactions |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Ivns1abp |
influenza virus NS1A binding protein |
|
multiple interactions |
ISO |
13 |
66,228,241 |
66,235,533 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases stability |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
|
multiple interactions |
ISO |
1 |
228,748,121 |
228,868,261 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
multiple interactions |
ISO |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krtcap2 |
keratinocyte associated protein 2 |
|
multiple interactions |
ISO |
2 |
181,417,284 |
181,421,280 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
multiple interactions |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
multiple interactions |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lmo7 |
LIM domain 7 |
|
multiple interactions |
ISO |
15 |
85,710,975 |
85,928,469 |
RGD:6480464 |
CTD |
| G |
Lpxn |
leupaxin |
|
multiple interactions |
ISO |
1 |
215,885,954 |
215,920,253 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
multiple interactions |
ISO |
1 |
54,412,081 |
54,417,571 |
RGD:6480464 |
CTD |
| G |
Pi4ka |
phosphatidylinositol 4-kinase, catalytic, alpha |
|
multiple interactions |
ISO |
11 |
85,610,281 |
85,726,603 |
RGD:6480464 |
CTD |
| G |
Pigh |
phosphatidylinositol glycan anchor biosynthesis, class H |
|
multiple interactions |
ISO |
6 |
101,713,237 |
101,722,655 |
RGD:6480464 |
CTD |
| G |
Pigk |
phosphatidylinositol glycan anchor biosynthesis, class K |
|
multiple interactions |
ISO |
2 |
250,976,109 |
251,037,852 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
multiple interactions |
ISO |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
multiple interactions |
ISO |
6 |
50,441,892 |
50,476,931 |
RGD:6480464 |
CTD |
| G |
Pla2g1b |
phospholipase A2, group IB, pancreas |
|
multiple interactions |
ISO |
12 |
42,405,475 |
42,415,189 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
EXP |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
multiple interactions |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
increases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
increases expression |
ISO |
1 |
82,612,833 |
82,624,575 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
multiple interactions |
ISO |
1 |
82,612,833 |
82,624,575 |
RGD:6480464 |
CTD |
| G |
Pln |
phospholamban |
|
multiple interactions |
ISO |
20 |
32,000,371 |
32,008,559 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
multiple interactions |
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Ppan |
peter pan homolog (Drosophila) |
|
multiple interactions |
ISO |
8 |
19,909,814 |
19,915,460 |
RGD:6480464 |
CTD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
multiple interactions |
ISO |
15 |
3,986,290 |
4,030,352 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
multiple interactions |
ISO |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
decreases expression |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
multiple interactions |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
multiple interactions |
ISO |
5 |
172,061,825 |
172,172,793 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
increases expression |
ISO |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
multiple interactions |
ISO |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptp4a3 |
protein tyrosine phosphatase type IVA, member 3 |
|
multiple interactions |
ISO |
7 |
111,462,191 |
111,468,045 |
RGD:6480464 |
CTD |
| G |
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
|
increases expression |
ISO |
4 |
76,659,507 |
76,662,465 |
RGD:6480464 |
CTD |
| G |
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
|
multiple interactions |
ISO |
4 |
76,659,507 |
76,662,465 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
multiple interactions |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
decreases expression |
EXP |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
RGD1304694 |
similar to CG9646-PA |
|
multiple interactions |
ISO |
7 |
122,969,934 |
123,005,873 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
multiple interactions |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
decreases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
multiple interactions |
ISO |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Sec11c |
SEC11 homolog C (S. cerevisiae) |
|
multiple interactions |
ISO |
18 |
62,096,585 |
62,112,929 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
multiple interactions |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf8 |
tumor necrosis factor receptor superfamily, member 8 |
|
multiple interactions |
ISO |
5 |
163,716,462 |
163,762,235 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnnc1 |
troponin C type 1 (slow) |
|
multiple interactions |
ISO |
16 |
6,639,357 |
6,642,331 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
|
multiple interactions |
ISO |
3 |
77,587,546 |
77,602,708 |
RGD:6480464 |
CTD |
| G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
|
decreases expression |
ISO |
3 |
77,587,546 |
77,602,708 |
RGD:6480464 |
CTD |
| G |
Tubgcp3 |
tubulin, gamma complex associated protein 3 |
|
multiple interactions |
ISO |
16 |
81,709,041 |
81,769,680 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
multiple interactions |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyr |
tyrosinase |
|
multiple interactions |
ISO |
1 |
143,641,257 |
143,746,315 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
multiple interactions |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
decreases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b35 |
UDP glucuronosyltransferase 2 family, polypeptide B35 |
|
increases expression |
ISO |
14 |
22,454,256 |
22,493,510 |
RGD:6480464 |
CTD |
| G |
Vasp |
vasodilator-stimulated phosphoprotein |
|
multiple interactions |
ISO |
1 |
78,621,494 |
78,636,762 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
multiple interactions |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vsnl1 |
visinin-like 1 |
|
multiple interactions |
ISO |
6 |
34,770,053 |
34,895,220 |
RGD:6480464 |
CTD |
cycloserine
|
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
dicloxacillin
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases response to substance |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
flucloxacillin
|
| G |
Crp |
C-reactive protein, pentraxin-related |
|
multiple interactions |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
affects response to substance |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
phenoxymethylpenicillin
|
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
increases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
piperacillin
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
sulbactam
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
Term paths to the root
|